logo
Select company
Select metric
$ -58.76MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
11
Sector
29
Industry
42
History
94
$ 0.8Close
$ 0.27 - $ 2.37 52-Week Range
Ticker Information

Ticker

BCAB

Company Name

BIOATLA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

BIOATLA INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BCAB - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 754K$ -59.52M$ -58.76M
3/31/2025$ 868K$ -61.88M$ -61.01M
12/31/2024$ 925K$ -69.78M$ -68.85M
9/30/2024$ 1.06M$ -81.82M$ -80.75M
6/30/2024$ 1.11M$ -104.56M$ -103.45M
3/31/2024$ 1.17M$ -119.24M$ -118.07M
12/31/2023$ 1.22M$ -123.46M$ -122.24M
9/30/2023$ 1.15M$ -124.08M$ -122.93M
6/30/2023$ 1.18M$ -116.53M$ -115.35M
3/31/2023$ 1.18M$ -109.69M$ -108.51M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BIOATLA INC's latest trailing twelve months (TTM) EBITDA stands at $ -33.46M.
  • Over the past 5 years, BIOATLA INC's average EBITDA has been $ -92.87M.
  • The median EBITDA for BIOATLA INC during this period was $ -99.62M
  • BIOATLA INC reached its highest EBITDA over the past 5 years at $ -33.46M.
  • The lowest EBITDA recorded by BIOATLA INC in the same timeframe $ -122.93M

BIOATLA INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
CRIS : CURIS INC $ -37.53MCARM : CARISMA THERAPEUTICS INC $ -45.68MCSCIF : COSCIENS BIOPHARMA INC $ -16.25MNXGL : NEXGEL INC $ -2.29MMRKR : MARKER THERAPEUTICS INC $ -14.56MNRXS : NEURAXIS INC $ -7.03MHCTI : HEALTHCARE TRIANGLE INC $ -4.08MLPCN : LIPOCINE INC $ -4.45MJAGX : JAGUAR HEALTH INC $ -38.7MDYAI : DYADIC INTERNATIONAL INC $ -5.09M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for BIOATLA INC is calculated as follows: EBIT [ $ -34.46M ] + DepAmor [ $ 1.01M ]
(=) EBITDA [ $ -33.46M ]

BCAB - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -122.93M

Minimum

Sep 30, 2023

$ -33.46M

Maximum

Dec 31, 2020

$ -92.87M

Average

$ -99.62M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.87M with a standard deviation of $ 166.99M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.87M
median$ 8.87M
std$ 166.99M